GH1 and acromegaly: Likely, the risk of apparent CAD is a consequence of concomitant traditional CVD risk factors rather than direct effects of GH or IGF-1 [7, 36, 63], and consequently, acromegaly treatment reduces risk of CAD via amelioration of CVD risk factors [65].